Package 42858-602-03

{"route": ["SUBLINGUAL"], "spl_id": "edbbdc14-dfb0-4ff4-87f3-b217d6bc36f7", "openfda": {"upc": ["0342858602037", "0342858601030"], "unii": ["5Q187997EE", "56W8MW3EN1"], "rxcui": ["351266", "351267"], "spl_set_id": ["794724a6-0fba-bc8d-ecdb-9e3be8ea2191"], "manufacturer_name": ["Rhodes Pharmaceuticals L.P."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (42858-602-03)", "package_ndc": "42858-602-03", "marketing_start_date": "20200413"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "42858-602_edbbdc14-dfb0-4ff4-87f3-b217d6bc36f7", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "42858-602", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Rhodes Pharmaceuticals L.P.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": "2 mg/1"}], "application_number": "ANDA205601", "marketing_category": "ANDA", "marketing_start_date": "20200413", "listing_expiration_date": "20271231"}